15 November
2024
GenIP Plc
("GenIP" or the
"Company")
GenIP congratulates NHIC on
its 10th Anniversary Milestone
GenIP is pleased to be a corporate sponsor of
the National Health Innovation Centre Singapore's (NHIC) 10th
Anniversary Appreciation dinner, which took place on 14th November
2024. The gathering brought together healthcare professionals,
industry leaders, and stakeholders from across the region to
recognise a decade of clinical innovations that have positively
impacted the healthcare sector.
Supporting the Future of Healthcare
Innovation
GenIP is delighted to join other key players in
championing healthcare innovation. Our GenAI-enhanced services aim
to accelerate the commercialisation of promising technologies that
can improve quality of life. The appreciation dinner was a unique
opportunity for GenIP to connect with innovators who share the same
commitment in contributing to Singapore's vibrant healthcare
landscape.
Ms Melissa Cruz, CEO of GenIP,
commented:
"We're honoured to be part of this milestone
event and look forward to collaborating with other visionaries to
drive innovation in the implementation and commercialisation of
healthcare technology."
Dr Pauline Tay, Director of NHIC,
commented:
"We are heartened to have the support of
companies, including GenIP. As we cross this milestone, we look
forward to continuing to work with our ecosystem partners and
industry colleagues to forge new innovations in healthcare
delivery."
For further
information regarding GenIP, please visit www.genip.ai, or
contact:
GenIP
Plc
Melissa Cruz,
CEO
Tel: +44 (0) 20 3368 3090
Redchurch
Communications (Financial PR)
John
Casey
genip@weareredchurch.com
This is a Reach announcement. Reach is an
investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute media only
/ non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulations would be disseminated as an
RNS regulatory announcement and not on Reach.
Notes to
Editors
About
GenIP
GenIP provides generative artificial
intelligence (GenAI) analytic services to help companies, research
institutions and venture funds assess and commercialise new
discoveries. GenIP combines expert human technical review with
GenAI algorithms to provide insightful and verified
services.
GenIP provides two complementary platform-based
services:
1.
Invention Evaluator: Provides bespoke research reports that assess
the market potential of new technological innovations and
discoveries using AI-driven proprietary software; and
2.
Vortechs: which is an executive recruitment platform that through
advanced machine learning algorithms and natural language
processing technologies assists in matching technology
organisations with experienced executives skilled in technology
commercialisation.
The Company believes that its integrated GenAI
service offerings will help organisations to evaluate and
commercialise their technological innovations.
Company
Strategy
GenIP's goal is to create a leading Generative
AI analytic services company. To achieve this, the Company has
established three strategic pillars:
●
Organically grow InventionEvaluator and Vortechs' revenue through
institutional and corporate connections as well as increase client
pipeline through marketing, advertising and social media
spend.
●
Expand the Generative AI service offerings within
InventionEvaluator and Vortechs' to reach new customers and improve
margins.
●
Bolt-on acquisitions of additional Generative AI services that are
helpful to our clients and have demonstrated initial market
traction.
Forward
looking statements
Certain statements contained in this
announcement constitute forward-looking statements. When used in
this announcement, the words "may", "would", "could", "will",
"intend", "plan", "anticipate", "believe", "seek", "propose",
"estimate", "expect", and similar expressions, as they relate to
the Company, are intended to identify forward-looking statements.
These statements include, but are not limited to, statements
regarding intentions, beliefs or current expectations concerning,
among other things, the Company's results of operations, financial
position, liquidity, prospects, growth, strategies and expectations
of the industry in which the Company operates.
Such statements reflect the Company's current
views with respect to future events and are subject to certain
risks, uncertainties and assumptions. Many factors could cause the
Company's actual results, performance or achievements to materially
differ from those described in this announcement Should one or more
of these risks or uncertainties materialise, or should assumptions
underlying forward-looking statements prove incorrect, actual
results may differ materially from those described in this
announcement as "intended", "planned", "anticipated", "believed",
"proposed", "estimated" or "expected".
For the avoidance of doubt, the contents of the
Company's website and any hyperlinks accessible from the Company's
website are not incorporated by reference into, and do not form
part of, this announcement and investors should not rely on
them.
-ENDS-
